Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-08 Purchase | 2024-02-12 4:58 pm | NANOPHASE TECHNOLOGIES Corp | NANX | WHITMORE BRADFORD T 10% Owner | 3,824,864 | $0.4 | $1,529,946 | 25,524,811 (Indirect Direct) | View |
| 2024-02-07 Purchase | 2024-02-09 1:00 pm | Clearside Biomedical Inc. | CLSD | WHITMORE BRADFORD T 10% Owner | 444,444 | $1.35 | $599,999 | 7,289,630 (Indirect Direct) | View |
| 2023-12-06 Purchase | 2023-12-08 4:14 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 15,877 | $6.9877 | $110,943 | 6,201,013 (Indirect Direct) | View |
| 2023-11-27 Purchase | 2023-11-29 4:19 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 25,100 | $7.1973 | $180,651 | 6,185,136 (Indirect Direct) | View |
| 2023-10-30 Purchase | 2023-11-01 4:44 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 13,871 | $7.1366 | $98,991 | 6,156,764 (Indirect Direct) | View |
| 2023-10-30 Purchase | 2023-11-01 4:24 pm | Clearside Biomedical Inc. | CLSD | WHITMORE BRADFORD T 10% Owner | 135,778 | $0.73539 | $99,849 | 6,400,742 (Indirect Direct) | View |
| 2023-09-13 Purchase | 2023-09-15 3:40 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 11,000 | $10.15 | $111,613 | 6,146,165 (Indirect Direct) | View |
| 2023-08-21 Purchase | 2023-08-23 4:26 pm | NANOPHASE TECHNOLOGIES Corp | NANX | WHITMORE BRADFORD T 10% Owner | 85,847 | $0.91906 | $78,899 | 31,059,732 (Indirect Direct) | View |
| 2023-06-12 Purchase | 2023-06-14 4:29 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 80,598 | $4.9393 | $398,096 | 6,135,165 (Indirect Direct) | View |
| 2023-06-02 Purchase | 2023-06-05 3:22 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 5,964 | $4.4001 | $26,242 | 6,054,567 (Indirect Direct) | View |
| 2023-05-30 Purchase | 2023-06-01 4:55 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 33,963 | $4.3103 | $146,392 | 6,048,603 (Indirect Direct) | View |
| 2023-05-30 Purchase | 2023-06-01 4:34 pm | NANOPHASE TECHNOLOGIES Corp | NANX | WHITMORE BRADFORD T 10% Owner | 16,400 | $1.1785 | $19,328 | 30,973,885 (Indirect Direct) | View |
| 2023-05-17 Purchase | 2023-05-19 4:16 pm | NANOPHASE TECHNOLOGIES Corp | NANX | WHITMORE BRADFORD T 10% Owner | 66,890 | $0.84016 | $56,199 | 30,957,485 (Indirect Direct) | View |
| 2023-05-09 Purchase | 2023-05-11 4:51 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 28,788 | $4.0566 | $116,783 | 6,014,640 (Indirect Direct) | View |
| 2023-03-09 Purchase | 2023-03-13 4:37 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 30,000 | $4.0631 | $121,893 | 5,985,852 (Indirect Direct) | View |
| 2022-12-14 Purchase | 2022-12-16 1:29 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 38,032 | $3.9956 | $151,962 | 5,955,852 (Indirect Direct) | View |
| 2022-12-15 Purchase(A) | 2022-12-16 10:17 am | NANOPHASE TECHNOLOGIES Corp | NANX | WHITMORE BRADFORD T 10% Owner | 300,488 | $1.1002 | $330,597 | 30,890,595 (Indirect Direct) | View |
| 2022-12-15 Purchase | 2022-12-15 4:22 pm | NANOPHASE TECHNOLOGIES Corp | NANX | WHITMORE BRADFORD T 10% Owner | 300,488 | $1.1002 | $330,597 | 30,880,595 (Indirect Direct) | View |
| 2022-12-06 Purchase | 2022-12-08 5:09 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 69,196 | $4.0281 | $278,729 | 5,917,820 (Indirect Direct) | View |
| 2022-12-06 Purchase | 2022-12-08 4:46 pm | NANOPHASE TECHNOLOGIES Corp | NANX | WHITMORE BRADFORD T 10% Owner | 178,768 | $1.1907 | $212,867 | 30,590,107 (Indirect Direct) | View |
| 2022-11-16 Purchase | 2022-11-18 4:28 pm | NANOPHASE TECHNOLOGIES Corp | NANX | WHITMORE BRADFORD T 10% Owner | 133,185 | $1.3928 | $185,498 | 30,411,339 (Indirect Direct) | View |
| 2022-08-17 Purchase | 2022-08-19 4:03 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 34,100 | $4.6225 | $157,628 | 5,848,624 (Indirect Direct) | View |
| 2022-08-02 Purchase | 2022-08-04 4:54 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 100,000 | $4.6749 | $467,486 | 5,814,524 (Indirect Direct) | View |
| 2022-06-06 Purchase | 2022-06-08 4:06 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 42,970 | $5.1024 | $219,252 | 5,714,524 (Indirect Direct) | View |
| 2022-02-24 Purchase | 2022-02-28 4:43 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 55,030 | $4.4465 | $244,690 | 5,671,554 (Indirect Direct) | View |
| 2021-12-21 Purchase | 2021-12-23 4:28 pm | NANOPHASE TECHNOLOGIES Corp | NANX | WHITMORE BRADFORD T 10% Owner | 7,731,573 | $4.1856 | $32,361,272 | 30,278,154 (Indirect Direct) | View |
| 2021-12-21 Sale | 2021-12-23 4:28 pm | NANOPHASE TECHNOLOGIES Corp | NANX | WHITMORE BRADFORD T 10% Owner | 7,731,573 | $4.1856 | $32,361,272 | 30,278,154 (Indirect Direct) | View |
| 2021-12-17 Purchase | 2021-12-20 4:11 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 53,251 | $5.5703 | $296,624 | 5,616,524 (Indirect Direct) | View |
| 2021-08-30 Sale | 2021-09-01 4:46 pm | Clearside Biomedical Inc. | CLSD | WHITMORE BRADFORD T 10% Owner | 420,285 | $6.9487 | $2,920,427 | 5,944,901 (Indirect Direct) | View |
| 2021-08-02 Purchase | 2021-08-04 3:55 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 25,200 | $7.9076 | $199,271 | 5,563,273 (Indirect Direct) | View |
| 2021-01-06 Purchase | 2021-01-07 09:49 am | Clearside Biomedical Inc. | CLSD | WHITMORE BRADFORD T 10% Owner | 350,750 | $2.851 | $999,988 | 6,365,186 (Indirect Direct) | View |
| 2020-12-24 Purchase | 2020-12-28 10:30 am | Clearside Biomedical Inc. | CLSD | WHITMORE BRADFORD T 10% Owner | 51,195 | $1.9513 | $99,897 | 6,014,436 (Indirect Direct) | View |
| 2020-12-02 Purchase | 2020-12-02 4:22 pm | Clearside Biomedical Inc. | CLSD | WHITMORE BRADFORD T 10% Owner | 53,900 | $1.949 | $105,051 | 5,963,241 (Indirect Direct) | View |
| 2020-11-24 Purchase | 2020-11-24 4:46 pm | Clearside Biomedical Inc. | CLSD | WHITMORE BRADFORD T 10% Owner | 62,000 | $1.6459 | $102,046 | 5,909,341 (Indirect Direct) | View |
| 2020-11-16 Purchase | 2020-11-16 4:36 pm | Clearside Biomedical Inc. | CLSD | WHITMORE BRADFORD T 10% Owner | 62,000 | $1.6924 | $104,929 | 5,847,341 (Indirect Direct) | View |
| 2020-08-12 Purchase(A) | 2020-08-13 4:28 pm | Clearside Biomedical Inc. | CLSD | WHITMORE BRADFORD T 10% Owner | 350,000 | $1.6334 | $571,680 | 5,785,341 (Indirect Direct) | View |
| 2020-08-12 Purchase | 2020-08-13 4:01 pm | Clearside Biomedical Inc. | CLSD | WHITMORE BRADFORD T 10% Owner | 350,000 | $1.6334 | $571,680 | 4,125,000 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2023-11-01 4:04 pm | N/A N/A | Clearside Biomedical Inc. | CLSD | WHITMORE BRADFORD T 10% Owner | 0 | $0 | 6,264,964 (Direct) | View |
| 2021-05-07 Conversion | 2021-05-11 4:37 pm | N/A N/A | NANOPHASE TECHNOLOGIES Corp | NANX | WHITMORE BRADFORD T 10% Owner | 12,114,666 | $0.2 | 30,278,154 (Direct) | View |
| 2020-09-29 Other | 2020-10-01 4:34 pm | N/A N/A | NANOPHASE TECHNOLOGIES Corp | NANX | WHITMORE BRADFORD T 10% Owner | 2,433,300 | $0 | 27,049,199 (Direct) | View |